Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Masimo expected to grow through 2025 as it branches out, analyst says

March 16, 2018 By Danielle Kirsh

Masimo (Nasdaq: MASI) should enjoy growth through the middle of the next decade, thanks to its exploration of opportunities outside its core market that are more driven by hospital automation, according to a new equity research report out of Barclays.

Masimo is on track to having 8–10% top-line growth and 12–15% earnings per share growth through 2025, according to the Barclays report. The growth can be attributed to new market entry and further expanding the company’s Rainbow platform, Root and Patient SafetyNet.

The company already has its Root connectivity hub that allows for third-party access from outside of the hospital system. This means other companies can create technology that works with Root. Masimo also recently released its Telehealth Rad-97 for home monitoring.

Top-line growth is being driven by Masimo’s relationship with Philips in the install base and in the acuity monitoring market, according to the report. Masimo recently started offering Rainbow Lite SET sensors that enable the monitoring of the Masimo Oxygen Reserve Index. The sensors show an improved PVi to assess fluid responsiveness.

Masimo’s total available market is also expected to double by 2025, from the $3 billion it is today, at a 9% consumer annual growth rate.

The company’s recurring revenue base will see a 98% renewal rate with its Oximeter devices that are sold on contracts for five to seven years, according to the Barclays report, which said the company’s technology works well.  It’s hard for competitors to enter the space, the report said.

“Looking at near-term expectations, we think [Masimo] sets up well for 2018. Specifically, initial guidance includes an expectation for 9% product growth. We note this compares to 12% product growth in 2017 on an 11% comp in 2016,” said the report’s author Matthew Taylor. “We are impressed by the quality of the business, management team and pipeline, and like the potential for upside given our expectation for acceleration in the core business and new product uptake.”

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
Rockley Photonics
Rockley Photonics announces $81.5M private placement
Caretaker Medical VitalStream
FDA clears four new parameters for Caretaker Medical’s wireless patient monitoring system
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech